Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

28
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of...
28
Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

28
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
28

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Deciphering Freezing of Gait: What Neuropathology Reveals About an Episodic Phenomenon.

The European journal of neuroscience·2026
Same author

Cognitive, Motor and Oculomotor Contributions to the Trail Making Test in Progressive Supranuclear Palsy.

Movement disorders clinical practice·2026
Same author

A multimodal biomarker strategy to enhance diagnostic precision in neurodegenerative parkinsonism.

Nature medicine·2026
Same author

The study of epigenetic clocks in former professional contact sports athletes with repetitive head impacts.

Journal of neurology, neurosurgery, and psychiatry·2026
Same author

GWAS meta-analysis of cerebrospinal fluid Alzheimer's biomarkers reveals loci regulating lipids, brain volume and autophagy.

Nature communications·2026
Same author

The Uppsala APP Mutation Promotes Wild-Type Amyloid-β Aggregation and Deposition In Vivo.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026

Related Experiment Video

Updated: May 5, 2026

Sensitive Detection of Proteopathic Seeding Activity with FRET Flow Cytometry
12:31

Sensitive Detection of Proteopathic Seeding Activity with FRET Flow Cytometry

Published on: December 8, 2015

15.9K

4R-tau seeding activity reveals molecular subtypes in progressive supranuclear palsy.

Ivan Martinez-Valbuena1,2,3, Seojin Lee1,4, Enrique Santamaria5

  • 1Tanz Centre for Research in Neurodegenerative Diseases, University of Toronto, Toronto, ON, Canada.

Nature Communications
|December 31, 2025
PubMed
Summary
This summary is machine-generated.

Distinct high molecular weight tau assemblies drive aggregation in progressive supranuclear palsy (PSP) brains. Measuring tau seeding capacity may help stratify patients and guide targeted therapies for this neurodegenerative disease.

More Related Videos

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

18.0K
Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes
09:12

Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes

Published on: December 20, 2019

6.7K

Related Experiment Videos

Last Updated: May 5, 2026

Sensitive Detection of Proteopathic Seeding Activity with FRET Flow Cytometry
12:31

Sensitive Detection of Proteopathic Seeding Activity with FRET Flow Cytometry

Published on: December 8, 2015

15.9K
Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains
09:27

Sequential Extraction of Soluble and Insoluble Alpha-Synuclein from Parkinsonian Brains

Published on: January 5, 2016

18.0K
Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes
09:12

Modulation of Tau Subcellular Localization as a Tool to Investigate the Expression of Disease-related Genes

Published on: December 20, 2019

6.7K

Area of Science:

  • Neuroscience
  • Biochemistry
  • Pathology

Background:

  • Progressive supranuclear palsy (PSP) is a neurodegenerative disease.
  • Abnormal tau protein accumulation causes motor and cognitive symptoms in PSP.
  • Clinical heterogeneity in PSP remains unexplained.

Purpose of the Study:

  • Investigate molecular differences in tau protein across PSP brains.
  • Determine the role of high molecular weight (HMW) tau assemblies in PSP.
  • Identify biomarkers for patient stratification and therapeutic development.

Main Methods:

  • Biochemical examination of tau species.
  • Seed amplification assays to measure tau aggregation activity.
  • Proteomic profiling and spatial transcriptomics.

Main Results:

  • Distinct HMW tau assemblies show varying abundance and activity in PSP brains.
  • HMW tau species exhibit the strongest aggregation activity in the primary motor cortex.
  • High tau seeding activity correlates with altered immune and metabolic pathways.

Conclusions:

  • Tau seeding activity reflects molecular heterogeneity in PSP.
  • Measuring 4R-tau seeding capacity can aid patient stratification.
  • This approach may guide the development of targeted PSP therapies.